Saturday, October 23, 2021
wellness India Expo
Home Tags R&D

Tag: R&D

TDB Foundation Day: Must nurture the startup ecosystem, says Dr Jitendra...

Addressing the 25th Foundation Day of the TDB, Union S&T Minister emphasized that the board must discover and nurture the startup ecosystem for successful product development...........................

UnivLabs develops India’s first indigenous 4K endoscope tower

India’s own 4K Endoscope tower comes with world standard functionality, an affordable price tag, a cost effective acquisition model and an innovative service on call mechanism..........................

Syngene clocks 12% growth in FY21 revenue at Rs. 2,184 crore

Underlying revenue from operations (excluding export incentives) for the quarter grew 13% compared with the same period last year and by 12% for the full year......................

Govt fast tracks emergency approvals for foreign produced COVID-19 vaccines

A lot many vaccines are expected to be granted Emergency Use Authorization in other countries for expanding the basket of vaccines for domestic use and hasten the pace and coverage of vaccination....................

FMC India launches Science Leaders Scholarship Program to promote agricultural research

50 percent of scholarships to be allocated to female candidates................

A joint initiative to establish collaborative research platform

Ashoka University and IIT, Delhi will contribute matching funds to support collaborative and interdisciplinary education and research initiatives through a joint call for proposals..................

COVID-19 put a spotlight on sci-tech & thus 30% hike in...

This year the budget of DBT includes a Special AtmaNirbhar Package of Rs. 900 Crores for Mission COVID Suraksha – The Indian Vaccine Development Mission......................

DST releases draft of 5th national STI policy for public consultation

The new policy, STIP, revolves around the core principles of being decentralized, evidence-informed, bottom-up, experts-driven, and inclusive. Suggestions, comments and inputs on the draft policy may be shared by Monday the 25th January 2021 on email: [email protected]

Jubilant launches JUBI-R, its generic version of COVID-19 drug remdesivir in...

Jubilant Generics, a subsidiary of Jubilant Life Sciences has launched remdesivir for injection under the brand name ‘JUBI-R’ in the Indian market at a price of INR 4,700 per vial of 100 mg (lyophilized injection)........................

JNCASR spinoff launches molecular probes for use in COVID-19 test kits

The company has launched indigenous fluorescence probes and Polymerase chain reaction (PCR) mix for Reverse transcription-polymerase chain reaction (RT-PCR) detection which are molecular probes used in COVID-19 test kits.................